An autologous self-antigen differentially regulates expression of I-A glycoproteins and B7 costimulatory molecules on CD4- CD8- T helper cells

Journal of Leukocyte Biology

Volumn 66, Issue 1, 1999, Pages 120-126

  Walker, Mindi R ^a   White, Gregory A ^a   Nardella, John P ^a   Mannie, Mark D ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Antigen presentation; Experimental autoimmune encephalomyelitis multiple sclerosis; Major histocompatibility complex; T cell receptors; T lymphocytes

Indexed keywords

GLYCOPROTEIN; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; COMPLEX FORMATION; CYTOKINE PRODUCTION; HELPER CELL; IMMUNOPATHOGENESIS; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE ACTIVATION;

ANIMALIA; CAVIA PORCELLUS; SUS SCROFA;

EID: 0032992947     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.66.1.120     Document Type: Article

References (42)

1. Willenborg, D. O., Staykova, M. A. (1998) Approaches to the treatment of central nervous system autoimmune disease using specific neuroantigen. Immunol. Cell Biol. 76, 91-103.
2. Constantinescu, C. S., Hilliard, B., Fujioka, T., Bhopale, M. K., Calida, D., Rostami, A. M. (1998) Pathogenesis of neuroimmunologic diseases. Experimental models. Immunol. Res. 17, 217-227.
3. Kibler, R. F., Fritz, R. B., Chou, F. C.-H., Chou, C.-H. J., Peacocke, N. Y., Brown, N. M., McFarlin, D. E. (1977) Immune response of Lewis rats to peptide Cl (residues 68-88) of guinea pig and rat myelin basic proteins. J. Exp. Med. 146, 1323-1331.
4. Mannie, M. D., Rendall, S. K., Arnold, P. Y., Nardella, J. P., White, G. A. (1996) Anergy-associated T cell antigen presentation. A mechanism of infectious tolerance in experimental autoimmune encephalomyelitis. J. Immunol. 157, 1062-1070.
5. Johnson, B. D., Nardella, J. P., McConnell, T. J., Mannie, M. D. (1997) Acquired resistance to experimental autoimmune encephalomyelitis is independent of V beta usage. Cell. Immunol. 179, 55-65.
6. Mannie, M. D., Rosser, J. M., White, G. A. (1995) Autologous rat myelin basic protein is a partial agonist that is converted into a full antagonist upon blockade of CD4. Evidence for the integration of efficacious and nonefficacious signals during T cell antigen recognition. J. Immunol. 154, 2642-2654.
7. Mannie, M. D., White, G. A., Nardella, J. P., Davidian, D. K., Arnold, P. Y. (1998) Partial agonism elicits an enduring phase of T cell-mediated antigen presentation. Cell. Immunol. 186, 83-93.
8. Evavold, B. D., Allen, P. M. (1991) Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science 252, 1308-1310.
9. Evavold, B. D., Sloan-Lancaster, J., Hsu, B. L., Allen, P. M. (1993) Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides. J. Immunol. 150, 3131-3140.
10. Jameson, S. C., Bevan, M. J. (1995) T cell receptor antagonists and partial agonists. Immunity 2, 1-11.
11. Madrenas, J., Wange, R. L., Wang, J. L., Isakov, N., Samelson, L. E., Germain, R. N. (1995) Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science 267, 515-518.
12. Madrenas, J., Germain, R. N. (1996) Variant TCR ligands: new insights into the molecular basis of antigen-dependent signal transduction and T-cell activation. Semin. Immunol. 8, 83-101.
13. + T cells in response to antagonist ligands. J. Exp. Med. 184, 149-157.
14. Sloan-Lancaster, J., Allen, P. M. (1996) Altered peptide ligand-indueed partial T cell activation: molecular mechanisms and role in T cell biology. Annu. Rev. Immunol. 14, 1-27.
15. + T cells. I. Involvement of the CD80-CD28 adhesion molecules. J. Immunol. 155, 118-127.
16. + T cells by activated T cell stimulators. Eur. J. Immunol. 24, 2457-2461.
17. + T-cell clones presenting and simultaneously responding to an antigen die of apoptosis. Cell. Immunol. 161, 72-78.
18. Lamb, J. R., Feldmann, M. (1984) Essential requirement for major histocompatibility complex recognition in T cell tolerance induction. Nature 308, 72-74.
19. LaSalle, J. M., Hafler, D. A. (1994) T cell anergy. FASEB J. 8, 601-608.
20. Pichler, W. J., Wyss-Coray, T. (1994) T cells as antigen-presenting cells. Immunol. Today 15, 312-315.
21. Fowlkes, B. J., Schweighoffer, E. (1995) Positive selection of T cells. Curr. Opin. Immunol. 7, 188-195.
22. Hogquist, K. A., Jameson, S. C., Heath, W. R., Howard, J. L., Bevan, M. J., Carbone, F. R. (1994) T cell receptor antagonist peptides induce positive selection. Cell 76, 17-27.
23. Jameson, S. C., Hogquist, K. A., Bevan, M. J. (1994) Specificity and flexibility in thymie selection. Nature 369, 750-752.
24. Jameson, S. C., Hogquist, K. A., Bevan, M. J. (1995) Positive selection of thymocytes. Annu. Rev. Immunol. 13, 93-126.
25. Wang, R., Nelson, A., Kimachi, K., Grey, H. M., Farr, A. G. (1998) The role of peptides in thymic positive selection of class II major histocompatibility complex-restricted T cells. Proc. Natl. Acad. Sci. USA 95, 3804-3809.
26. Arnold, P. Y., Davidian, D. K., Mannie, M. D. (1997) Antigen presentation by T cells: T cell receptor ligation promotes antigen acquisition from professional antigen-presenting cells. Eur. J. Immunol. 27, 3198-3205.
27. McMaster, W. R., Williams, A. F. (1979) Monoclonal antibodies to Ia antigens from rat thymus: cross reactions with mouse and human and use in purification of rat Ia glycoproteins. Immunol. Rev. 47, 117-137.
28. Maeda, K., Sato, T., Azuma, M., Yagita, H., Okumura, K. (1997) Characterization of rat CD80 and CD86 by molecular cloning and mAb. Intern. Immunol. 9, 993-1000.
29. Kenakin, T. (1995) Agonist-receptor efficacy. II. Agonist trafficking of receptor signals. Trends Pharmacol. Sci. 16, 232-238.
30. Kenakin, T. (1995) Agonist-receptor efficacy. I: Mechanisms of efficacy and receptor promiscuity. Trends Pharmacol. Sci. 16, 188-192.
31. Limbird, L. E. (1985) Cell Surface Receptors: a Short Course on Theory and Methods. Boston: Martin Nijhoff.
32. Yoon, S. T., Dianzani, U., Bottomly, K., Janeway, C. A., Jr. (1994) Both high and low avidity antibodies to the T cell receptor can have agonist or antagonist activity. Immunity 1, 563-569.
33. Mannie, M. D., Nardella, J. P., White, G. A., Arnold, P. Y., Davidian, D. K. (1998) Class II MHC/peptide complexes on T cell antigen-presenting cells: agonistic antigen recognition inhibits subsequent antigen presentation. Cell. Immunol. 186, 111-120.
34. + T cell responses: the alternative approaches. Annu. Rev. Immunol. 15, 297-322.
35. + T cells. J. Exp. Med. 182, 1591-1596.
36. Pfeiffer, C., Stein, J., Southwood, S., Ketelaar, H., Sette, A., Bottomly, K. (1995) Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J. Exp. Med. 181, 1569-1574.
37. + T cell differentiation. J. Immunol. 159, 5956-5963.
38. Kuchroo, V. K., Das, M. P., Brown, J. A., Ranger, A. M., Zamvil, S. S., Sobel, R. A., Weiner, H. L., Nabavi, N., Glimcher, L. H. (1995) B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80, 707-718.
39. Freeman, G. J., Boussiotis, V. A., Anumanthan, A., Bernstein, G. M., Ke, X. Y., Rennert, P. D., Gray, G. S., Gribben, J. G., Nadler, L. M. (1995) B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 2, 523-532.
40. Tsuyuki, S., Tsuyuki, J., Einsle, K., Kopf, M., Coyle, A. J. (1997) Costimulation through B7-2 (CD86) is required for the induction of a lung mucosal T helper cell 2 (TH2) immune response and altered airway responsiveness. J. Exp. Med. 185, 1671-1679.
41. Nakajima, A., Watanabe, N., Yoshino, S., Yagita, H., Okumura, K., Azuma, M. (1997) Requirement of CD28-CD86 co-stimulation in the interaction between antigen-primed T helper type 2 and B cells. Int. Immunol. 9, 637-644.
42. Mannie, M. D. (1999) Immunological self/nonself discrimination: integration of self versus nonself during cognate T cell interactions with antigen presenting cells. Immunol. Res., 19, 65-88.